FDA Approves Tembexa

FDA Approves Tembexa (brincidofovir) for the Treatment of Smallpox DURHAM, N.C., June 04, 2021 (GLOBE NEWSWIRE) — Chimerix (NASDAQ:CMRX), a biopharmaceutical company focused on accelerating the development of medicines to […]

» Read more

FDA Approves Zynlonta

FDA Approves Zynlonta (loncastuximab tesirine-lpyl) for Relapsed or Refractory Diffuse Large B-Cell Lymphoma LAUSANNE, Switzerland–(BUSINESS WIRE) APRIL 23, 2021 — ADC Therapeutics SA (NYSE: ADCT) today announced that the U.S. […]

» Read more

Osteovan

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. OSTEOVAN® Zoledronic acid Consumer Medicine Information What is in this leaflet This leaflet answers some common questions […]

» Read more

Chemmart Clomipramine

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. CHEMMART CLOMIPRAMINE Contains the active ingredient, clomipramine (as clomipramine hydrochloride) Consumer Medicine Information What is in this […]

» Read more

Serc

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. SERC® betahistine dihydrochloride Consumer Medicine Information (CMI) What is in this leaflet This leaflet answers some common […]

» Read more

Voriconazole APOTEX

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. VORICONAZOLE APOTEX TABLETS Contains the active ingredient voriconazole Consumer Medicine Information What is in this leaflet Read […]

» Read more

Clofen

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. CLOFEN baclofen CONSUMER MEDICINE INFORMATION What is in this leaflet This leaflet answers some common questions about […]

» Read more
1 2 3 21